← Back to patent-cliff list
CAS 2087469-17-6
10-[(4-Methoxyphenyl)methyl]-8-methyl-1,4-dioxa-8-azaspiro[4.6]undecan-9-one
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Eptazocine hydrobromide | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1,4-Dioxaspiro[4.5]decan-8-one→Hydroxylamine hydrochloride→N-{1,4-dioxaspiro[4.5]decan-8-ylidene}hydroxylamine→N-[(Methanesulfonyl)oxy]-1,4-dioxaspiro[4.5]decan-8-imine→10-[(4-Methoxyphenyl)methyl]-8-methyl-1,4-dioxa-8-azaspiro[4.6]undecan-9-one→1,4-Dioxa-8-azaspiro[4.6]undecan-9-one→Iodomethane→8-Methyl-1,4-dioxa-8-azaspiro[4.6]undecan-9-one→4-Methoxybenzyl chloride→4-Nitrobenzoic acid 10-[(4-methoxyphenyl)methyl]-8-methyl-1,4-dioxa-8-azaspiro[4.6]undecane→6-[(4-Methoxyphenyl)methyl]-1-methylazepan-4-one→6-[(4-Methoxyphenyl)methyl]-1,4-dimethylazepan-4-ol
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.